To sum up, our results indicated that MYBL2 was able to directly bind to the promoter region of UBE2C and activate transcription of UBE2C, thereby inhibiting cell apoptosis and DNA damage, promoting cell viability and DDP resistance in GC cells. The gene discussed is UBE2C; the disease is gastric cancer.